19 completed, 6 terminated, 2 active not recruiting, 1 not yet recruiting. 4 Phase 2, 4 Phase 4, 2 Phase 3.
By phase and status
Follow Janssen-Cilag, S.A.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
A Real-World Study of Guselkumab Persistence and Effectiveness in Participants With Crohn's Disease or Ulcerative Colitis
Colitis, Ulcerative, Crohn Disease | | Not yet recruiting | 200 | 2026-10-30 | 2026-09-30 |
Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.
Iberdomide, Dexamethasone, Daratumumab - Multiple Myeloma | Phase 2 | Active not recruiting | 140 | 2022-12-15 | 2026-05-08 |
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
Esketamine - Depression | Phase 3 | Completed | 41 | 2020-09-08 | 2023-09-14 |
A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c)
Symtuza® (TAF/FTC/DRV/c), ABC/3TC/DTG + Symtuza® (TAF/FTC/DRV/c) - HIV Infections | Phase 4 | Completed | 78 | 2018-12-04 | 2022-06-22 |
Treatment Resistant Depression in America Latina
Depressive Disorder, Treatment-Resistant | | Completed | 1539 | 2017-09-27 | 2025-04-27 |
Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice
HIV Infections | | Completed | 762 | 2016-12-23 | 2020-02-05 |
Ibrutinib in Combination With Rituximab in Patients With Indolent Clinical Forms of MCL
IBRUTINIB, Rituximab - Mantle Cell Lymphoma | Phase 2 | Active not recruiting | 50 | 2016-05-18 | 2026-03-27 |
Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to ASCT
Ibrutinib, Rituximab, Gemcitabine - Diffuse Large B-Cell Lymphoma | Phase 2 | Completed | 64 | 2016-04-07 | 2024-10-10 |
Registry for Analysis of Compliance in Colombian Participants With Rheumatoid Arthritis Exposed to Golimumab
Golimumab - Rheumatoid Arthritis | | Terminated | 37 | 2015-03-01 | 2017-02-13 |
Efficacy/Safety Study of R-CHOP vs Bortezomib-R-CAP for Young Patients With Diffuse Large B-cell Lymphoma With Poor IPI.
Bortezomib, Rituximab, Cyclophosphamide - Diffuse, Large B-Cell, Lymphoma | Phase 2 | Completed | 121 | 2013-10-03 | 2018-09-19 |
The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease
Galantamine - Alzheimer Disease | Phase 4 | Terminated | 1 | 2011-05-01 | 2014-05-01 |
FYS Study: Epidemiological, Multicentre, Cross-sectional Study in a Clinical Practice Environment, About the Relationship Between Functioning Status and the Quality of Sleep Perceived by Schizophrenic Outpatients in Spain
Functioning assessment, Quality of sleep assessment - Schizophrenia | | Completed | 709 | 2010-11-01 | 2013-03-08 |
An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia
Patient assessment - Schizophrenia, Schizoaffective Disorder | | Completed | 1809 | 2010-11-01 | 2012-02-14 |
A Study to Assess the Clinical Profile of Patients in Spain With Moderate to Severe Psoriasis.
Clinical profile of patients, Patient Preferences about treatment, Quality of Life - Psoriasis | | Completed | 1042 | 2010-10-01 | 2013-05-06 |
A Study to Evaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer's Disease | | Completed | 925 | 2008-06-01 | 2012-10-31 |
The Molecular Characterization of Multiple Myeloma at Relapse
Bone marrow examination, Blood samples - Multiple Myeloma | | Completed | 134 | 2008-03-01 | 2016-01-07 |
Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With Schizophrenia
Paliperidone ER - Schizophrenia | Phase 4 | Completed | 95 | 2008-02-01 | 2013-03-15 |
A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis
Gynoclin V, Vagitrol V - Vaginitis, Infectious Vaginosis | Phase 3 | Completed | 160 | 2007-12-01 | 2013-12-24 |
Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)
Visual analogue scales (EVAs) - Cancer Pain | | Completed | 271 | 2007-11-01 | 2013-02-11 |
Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia
No intervention - Schizophrenia | | Completed | 2339 | 2006-08-01 | 2014-03-19 |
Showing 20 of 28. Sign in to see all of them.
Conditions studied
Schizophrenia (9) · Psychotic Disorders (6) · Depression (3) · Alzheimer Disease (2) · Cancer Pain (2) · Gastroesophageal Reflux (2) · HIV Infections (2) · Lymphoma, Large B-Cell, Diffuse (2) · Multiple Myeloma (2) · Pain (2) · Patient Compliance (2) · Recurrence (2) · Sleep Initiation and Maintenance Disorders (2) · Arthritis, Rheumatoid (1) · Bipolar Disorder (1)
Interventions
Rituximab (3) · Antipsychotic Agents (2) · Dexamethasone (2) · Risperidone (2) · ibrutinib (2) · Antidepressive Agents (1) · Blood Specimen Collection (1) · Bone Marrow Examination (1) · Bortezomib (1) · Cyclophosphamide (1) · Doxorubicin (1) · Esketamine (1) · Galantamine (1) · Gemcitabine (1) · Oxaliplatin (1)
Countries
Spain (7) · Colombia (3) · Mexico (3) · Argentina (2) · Brazil (1) · Denmark (1)
Top investigators
Annette J Vangsted, MD, DMSc (1) · Dan Kristensen, MD (1) · Dolores Caballero, MD (1) · Finn C Nielsen, MD, DMSc (1)
Results publications
PMID 22448928, PMID 27027250, PMID 31236601, PMID 33501995, PMID 34463905, PMID 35030036
NIH funding
2009 (1), 2015 (1)